<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03443869</url>
  </required_header>
  <id_info>
    <org_study_id>8228-002</org_study_id>
    <secondary_id>2017-001055-30</secondary_id>
    <secondary_id>MK-8228-002</secondary_id>
    <nct_id>NCT03443869</nct_id>
  </id_info>
  <brief_title>Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)</brief_title>
  <official_title>A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of MK-8228 (Letermovir) Versus Valganciclovir for the Prevention of Human Cytomegalovirus (CMV) Disease in Adult Kidney Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the efficacy of letermovir (LET) versus
      valganciclovir (VGCV) in preventing CMV disease in adult kidney transplant recipients. The
      primary hypotheses are that LET is non-inferior to VGCV; and if non-inferiority is
      demonstrated, that LET is superior to VGCV, in preventing CMV disease through 52 weeks
      post-transplant.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2018</start_date>
  <completion_date type="Anticipated">September 19, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 19, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CMV Disease 52 Weeks</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Percentage of participants with adjudicated CMV disease through 52 weeks post-transplant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CMV Disease 28 Weeks</measure>
    <time_frame>Up to 28 weeks</time_frame>
    <description>Percentage of participants with adjudicated CMV disease through 28 weeks post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time To Onset</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Time to onset of adjudicated CMV disease through 52 weeks post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AE</measure>
    <time_frame>Up to week 30</time_frame>
    <description>Percentage of participants with any AE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug-related Serious AE (SAE)</measure>
    <time_frame>Up to week 52</time_frame>
    <description>Percentage of participants with any drug-related SAE</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>CMV Disease</condition>
  <arm_group>
    <arm_group_label>Letermovir</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Letermovir (LET) 480mg (or 240 mg when co-administered with cyclosporin A) tablet orally; placebo to VGCV tablet orally once daily; and 400 mg capsule of acyclovir (ACV) orally every 12 hours for 28 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Valganciclovir</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>900 mg Valganciclovir (VGCV) tablet orally, once daily; placebo to LET tablet orally once daily; and placebo to ACV orally every 12 hours for 28 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Letermovir</intervention_name>
    <description>LET 480mg (or 240 mg when co-administered with cyclosporin A) once daily for 28 weeks</description>
    <arm_group_label>Letermovir</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valganciclovir</intervention_name>
    <description>900 mg VGCV tablet orally, once daily for 28 weeks</description>
    <arm_group_label>Valganciclovir</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acyclovir (ACV)</intervention_name>
    <description>400 mg over-encapsulated ACV tablet orally, every 12 hours for 28 weeks</description>
    <arm_group_label>Letermovir</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to ACV</intervention_name>
    <description>Over-encapsulated placebo tablet orally, every 12 hours for 28 weeks</description>
    <arm_group_label>Valganciclovir</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to LET</intervention_name>
    <description>Placebo to LET tablet orally, once daily for 28 weeks</description>
    <arm_group_label>Valganciclovir</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to VGCV</intervention_name>
    <description>Placebo to VGCV tablet orally, once daily for 28 weeks</description>
    <arm_group_label>Letermovir</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a documented negative serostatus for CMV within 180 days prior to randomization.

          -  Anticipate receiving a primary or secondary allograft kidney from a CMV IgG
             seropositive (D+) donor at the time of screening AND have received a primary or
             secondary allograft kidney from a documented D+ donor at the time of randomization.

          -  Be within 0 (i.e. day of transplantation) to 7 days (inclusive) post-kidney transplant
             at the time of randomization.

          -  Males agree to use contraception during the treatment period, and for at least 90 days
             after the last dose of study treatment, and refrain from donating sperm during this
             period.

          -  Female is not pregnant, not breastfeeding, and is not a woman of childbearing
             potential (WOCBP), OR if a WOCBP, agrees to follow the contraception guidance during
             the treatment period and for at least 90 days after the last dose of study treatment.

        Exclusion Criteria:

          -  Has received a previous solid organ transplant or hematopoietic stem cell transplant
             (HSCT). Note: Participants who have received a prior primary allograft kidney may be
             enrolled, provided that all other inclusion/exclusion criteria are met.

          -  Is a multi-organ transplant recipient (e.g. kidney-pancreas). Double kidney transplant
             recipients (i.e. transplant of two kidneys from the same donor to the same recipient
             simultaneously) will be excluded.

          -  Has a history of CMV disease or suspected CMV disease within 6 months prior to
             randomization.

          -  Has suspected or known hypersensitivity to active or inactive ingredients of LET
             formulations, VGCV, GCV, and/or ACV formulations.

          -  Is on dialysis or plasmapheresis at the time of randomization. Dialysis includes
             hemofiltration.

          -  Has Child-Pugh Class C severe hepatic insufficiency at screening.

          -  Has both moderate hepatic insufficiency AND moderate-to-severe renal insufficiency at
             screening.

          -  Has any uncontrolled infection on the day of randomization.

          -  Has documented positive results for human immunodeficiency virus antibody (HIV-Ab)
             test at any time prior to randomization, or for hepatitis C virus antibody (HCV-Ab)
             and with detectable HCV ribonucleic acid (RNA) within 90 days prior to randomization,
             or hepatitis B surface antigen (HBsAg) within 90 days prior to randomization.

          -  Requires mechanical ventilation, or is hemodynamically unstable, at the time of
             randomization.

          -  Has a history of malignancy â‰¤5 years prior to signing informed consent.

          -  Is pregnant or expecting to conceive, is breastfeeding, or plans to breastfeed from
             the time of consent through at least 90 days following cessation of study therapy.

          -  Is expecting to donate eggs or sperm starting from the time of consent through at
             least 90 days following cessation of study therapy.

          -  Has received within 30 days prior to randomization or plans to receive during the
             study any of the following anti-CMV IgG antibody treatment or anti-CMV drug therapy
             including the following: Cidofovir, CMV hyper-immune globulin, Any investigational CMV
             antiviral agent/biologic therapy.

          -  Has received within 7 days prior to randomization or plans to receive during the study
             any of the following anti-CMV drug therapy: LET, GCV, VGCV, Foscarnet, ACV,
             Valacyclovir, Famciclovir.

          -  Is a user of recreational or illicit drugs or has had a recent history (within the
             last year) of drug or alcohol abuse or dependence.

          -  Is currently participating or has participated in a study with an unapproved
             investigational compound or device within 28 days, or 5Ã— half-life of the
             investigational compound whichever is longer, of initial dosing on this study.

          -  Has previously participated in this study or any other study involving LET.

          -  Has previously participated or is currently participating in any study involving
             administration of a CMV vaccine or another CMV investigational agent, or is planning
             to participate in a study of a CMV vaccine or another CMV investigational agent during
             the course of this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Toll Free Number</last_name>
    <phone>1-888-577-8839</phone>
    <email>Trialsites@merck.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UAB ( Site 0269)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>205-934-5191</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLA Medical Center ( Site 0266)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>310-794-8516</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center ( Site 0271)</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>916-734-8033</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California-San Francisco ( Site 0236)</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>415-353-8389</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford Health Care ( Site 0235)</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>650-723-7362</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Emory Clinic ( Site 0247)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Chicago ( Site 0251)</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>773-702-1665</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University ( Site 0261)</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>317-948-0633</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation ( Site 0238)</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>504-842-5527</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center ( Site 0234)</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>410-328-0303</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital ( Site 0232)</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>443-287-4694</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital ( Site 0244)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital ( Site 0242)</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>313-916-3709</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center ( Site 0272)</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>402-559-8609</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Barnabas Medical Center ( Site 0250)</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <zip>07039</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>973-322-8467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai ( Site 0256)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>212-241-0255</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center ( Site 0255)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>212-305-3839</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital - Weill Cornell Medical Center ( Site 0276)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>212-746-6320</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center ( Site 0243)</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>919-613-6472</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center ( Site 0260)</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>336-716-9353</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center ( Site 0264)</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>614-293-4997</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania ( Site 0270)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>215-662-4007</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh ( Site 0252)</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>412-648-6553</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina ( Site 0257)</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>843-792-8358</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center ( Site 0275)</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>615-343-8010</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University ( Site 0245)</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>804-828-4090</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center ( Site 0246)</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>206-598-1041</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital El Cruce Nestor Carlos Kirchner ( Site 0351)</name>
      <address>
        <city>Florencio Varela</city>
        <state>Buenos Aires</state>
        <zip>B1888AAE</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+541142109000x5110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CEMIC ( Site 0352)</name>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Autonoma De Buenos Aires</state>
        <zip>C1431FWO</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+5411529901002880</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires ( Site 0188)</name>
      <address>
        <city>Caba</city>
        <state>Ciudad Autonoma De Buenos Aires</state>
        <zip>C1199ABD</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+541149590393</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de Nefrologia Nephrology S.A. ( Site 0182)</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1425APQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+541148022720</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de CardiologÃ­a de Corrientes Juana F. Cabral ( Site 0181)</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400AMZ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+5403794410000x211</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica de nefrologia urologia y enfermedades cardiovasculares ( Site 0354)</name>
      <address>
        <city>Santa Fe</city>
        <zip>S3000BPJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+543424537262547</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital ( Site 0005)</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61295156600</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital ( Site 0006)</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61298456848</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital ( Site 0004)</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61731765080</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital ( Site 0003)</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61882220900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monash Health-Monash Medical Centre ( Site 0008)</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61395943518</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital ( Site 0007)</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61393427000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitat Innsbruck ( Site 0033)</name>
      <address>
        <city>Innsbruck</city>
        <state>Tirol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4351250425931</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Universitaetskliniken Wien ( Site 0032)</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4314040068750</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Antwerpen ( Site 0041)</name>
      <address>
        <city>Edegem</city>
        <state>Antwerpen</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+3238213435</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires de Bruxelles - CUB - Hopital Erasme ( Site 0042)</name>
      <address>
        <city>Bruxelles</city>
        <state>Bruxelles-Capitale, Region De</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+3225553334</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven - Campus Gasthuisberg ( Site 0044)</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+3216345675</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital ( Site 0221)</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>7804072077</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital ( Site 0224)</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>6048755950</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital ( Site 0225)</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>604682234469048</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital ( Site 0222)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>4163404241</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Maisonneuve-Rosemont CIUSSS de l Est de L Ile de Montreal ( Site 0226)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>5142523817</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital San Vicente FundaciÃ³n - Rionegro ( Site 0205)</name>
      <address>
        <city>Rionegro</city>
        <state>Antioquia</state>
        <zip>054047</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+57444487173210</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica del Country ( Site 0208)</name>
      <address>
        <city>Bogota</city>
        <state>Distrito Capital De Bogota</state>
        <zip>110221</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+573188292989</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 0209)</name>
      <address>
        <city>Bogota</city>
        <state>Distrito Capital De Bogota</state>
        <zip>110311</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+573188292989</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Mayor Mederi CIMED ( Site 0206)</name>
      <address>
        <city>Bogota</city>
        <state>Distrito Capital De Bogota</state>
        <zip>110911</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+5715600520x4926</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sociedad de Cirugia de Bogota Hospital de San Jose ( Site 0203)</name>
      <address>
        <city>Bogota</city>
        <state>Distrito Capital De Bogota</state>
        <zip>111411</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+5713195779632</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardiovascular de Colombia ( Site 0210)</name>
      <address>
        <city>Floridablanca</city>
        <state>Santander</state>
        <zip>681004</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+573145840422</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacion Valle del Lili ( Site 0285)</name>
      <address>
        <city>Cali</city>
        <state>Valle Del Cauca</state>
        <zip>760032</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Centro Medico Imbanaco de Cali S.A ( Site 0201)</name>
      <address>
        <city>Cali</city>
        <state>Valle Del Cauca</state>
        <zip>760042</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+572682100012902</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Pasteur ( Site 0053)</name>
      <address>
        <city>Nice</city>
        <state>Alpes-Maritimes</state>
        <zip>51069</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33492037919</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux. Hopital Pellegrin ( Site 0055)</name>
      <address>
        <city>Bordeaux</city>
        <state>Gironde</state>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33556795538</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rangueil ( Site 0054)</name>
      <address>
        <city>Toulouse</city>
        <state>Haute-Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33561322335</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>C.H.R.U Bretonneau ( Site 0051)</name>
      <address>
        <city>Tours</city>
        <state>Indre-et-Loire</state>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33247478339</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Tenon ( Site 0061)</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33156016502</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover ( Site 0073)</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+495115323000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Essen ( Site 0074)</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+492017236552</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite Universitaetsmedizin Berlin ( Site 0071)</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4930450514002</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem AOK ( Site 0282)</name>
      <address>
        <city>Pecs</city>
        <state>Baranya</state>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+36303854374</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem ( Site 0284)</name>
      <address>
        <city>Szeged</city>
        <state>Csongrad</state>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+36302292085</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem ( Site 0281)</name>
      <address>
        <city>Budapest</city>
        <zip>1082</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+3613172166</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem. ( Site 0283)</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+36309834764</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale San Raffaele di Milano ( Site 0098)</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390226432575</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova U.O.C. Trapianti Rene e Pancreas ( Site 0091)</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390498213185</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Gemelli Instituto di Clinica Chirurgica ( Site 0093)</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+393473339597</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Citta della Salute e della Scienza di Torino ( Site 0096)</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390116335573</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Mexicano de Trasplantes S C ( Site 0212)</name>
      <address>
        <city>Cuernavaca</city>
        <state>Morelos</state>
        <zip>62448</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+52777110522</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centenario Hospital Miguel Hidalgo ( Site 0215)</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20259</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+524499157965</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0214)</name>
      <address>
        <city>Ciudad de Mexico</city>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+52015555135827</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cardiologia Ignacio Chavez ( Site 0213)</name>
      <address>
        <city>Mexico City</city>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+525555732911</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faicic S de RL de CV ( Site 0211)</name>
      <address>
        <city>Veracruz</city>
        <zip>91900</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+5212299327808</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital ( Site 0002)</name>
      <address>
        <city>Auckland</city>
        <zip>1142</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+649307494922955</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego ( Site 0162)</name>
      <address>
        <city>Wroclaw</city>
        <state>Dolnoslaskie</state>
        <zip>50-556</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny Dzieciatka Jezus ( Site 0165)</name>
      <address>
        <city>Warszawa</city>
        <state>Mazowieckie</state>
        <zip>02-006</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Szpital Wojewodzki w Poznaniu ( Site 0168)</name>
      <address>
        <city>Poznan</city>
        <state>Wielkopolskie</state>
        <zip>60-479</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48618212327</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pomorski Uniwersytet Medyczny ( Site 0167)</name>
      <address>
        <city>Szczecin</city>
        <state>Zachodniopomorskie</state>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge IDIBELL ( Site 0114)</name>
      <address>
        <city>L Hospitalet De Llobregat</city>
        <state>A CoruÃ±a [La CoruÃ±a]</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+349333590112189</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar ( Site 0121)</name>
      <address>
        <city>Barcelona</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34932483689</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall de Hebron ( Site 0112)</name>
      <address>
        <city>Barcelona</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34932746079</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic i Provincial de Barcelona ( Site 0113)</name>
      <address>
        <city>Barcelona</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34932275400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Doce de Octubre ( Site 0116)</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34913908000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet ( Site 0118)</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34976765624</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Georges University Hospitals NHS Foundation Trust. ( Site 0136)</name>
      <address>
        <city>London</city>
        <state>London, City Of</state>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+442087252455</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital ( Site 0356)</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+441213715859</phone>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Mexico</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>February 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2018</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valganciclovir</mesh_term>
    <mesh_term>Acyclovir</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf</ipd_description>
    <ipd_url>http://engagezone.msd.com/ds_documentation.php</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

